Clinical Application of Radiotherapy in Modern Oncology
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 33
Special Issue Editors
Interests: clinical trials; multimodal treatments; malignancies of the thoracic region; SCLC; NSCLC; translational research; radiation-induced side effects; applications
2. Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Interests: online adaptive radiotherapy; MR-guided radiotherapy; malignancies of the thoracic region; SCLC; NSCLC; hyperthermia therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Radiotherapy (RT) is an integral part of modern cancer treatment besides surgery and systemic treatment, including targeted therapy and immune checkpoint inhibition. It can be used in the management of almost all cancers as a curative treatment for palliate symptoms or as a prophylactic treatment. Recent advances, including intensity-modulated RT, volumetric-modulated arc therapy, stereotactic body RT, adaptive RT, MR guidance and modern brachytherapy, have improved radiation targeting, thereby limiting the radiation exposure of healthy tissues.
This Special Issue will cover the following important topics regarding the application of RT in oncology. The topics of interest include, but not restricted to, the following: brain metastasis, bone metastasis, brain tumors, head and neck cancers, lung cancer, mesothelioma, thymoma, thymic carcinoma, breast cancer, prostate cancer and sarcoma.
We look forward to your contributions and advancing our collective knowledge about the role of radiotherapy in modern oncology.
Dr. Lukas Käsmann
Dr. Fabian Weykamp
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at mdpi.longhoe.net by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain metastasis
- bone metastasis
- brain tumors
- head and neck cancers
- thoracic oncology
- breast cancer
- prostate cancer
- sarcoma
